Welcome to CADQAS UK & Europe
CADQAS CIC is an independent, not-for-profit community interest company set up to support the introduction & adoption of high-quality new cancer diagnostic & predictive tests (biomarkers).
Training
CADQAS CIC supports and provides training in the interpretation of on-slide biomarkers either on site or elsewhere in UK or Europe, using our mobile pathology classroom.
Training courses offered to date include biomarker interpretation in Non-Small Cell Lung Cancer (e.g. ALK (D5F3), PD-L1 (SP263)), Urothelial Carcinoma (PD-L1 (SP142)) and Triple Negative Breast Cancer (PD-L1 (SP142)). We also offer more general training courses on interpretation of diagnostic markers in lung and breast.
To be notified when future training courses are available please fill in the form below.
Please contact us if you would like to discuss the development of future training courses.
Proficiency Testing
CADQAS CIC offers digital interpretive proficiency testing worldwide on a selection of biomarkers. We offer circulations of a small number of digital slides approximately twice a year for each biomarker.
You will need to register in order to receive login information for future circulations. Please visit our Proficiency Testing page to find out more.